ACP

Altitude Crest Partners Portfolio holdings

AUM $234M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$234M
AUM Growth
+$84.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
34
New
Increased
Reduced
Closed

Top Buys

1
+$17.7M
2
+$10.7M
3
+$9.92M
4
GPCR icon
Structure Therapeutics
GPCR
+$8.79M
5
APLS icon
Apellis Pharmaceuticals
APLS
+$7.94M

Top Sells

1
+$11.2M
2
+$11M
3
+$7.33M
4
BBIO icon
BridgeBio Pharma
BBIO
+$4.41M
5
ROIV icon
Roivant Sciences
ROIV
+$3.72M

Sector Composition

1 Healthcare 99.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZYME icon
26
Zymeworks
ZYME
$1.71B
$1.53M 0.66%
+145,581
MGX icon
27
Metagenomi Therapeutics
MGX
$57.8M
$1.41M 0.6%
+133,333
TRML
28
DELISTED
Tourmaline Bio
TRML
$1.09M 0.46%
+47,400
ALNY icon
29
Alnylam Pharmaceuticals
ALNY
$43.4B
$29.9K 0.01%
+200
SRZNW icon
30
Surrozen Inc Warrant
SRZNW
$12.5K 0.01%
384,573
AMAM
31
DELISTED
Ambrx Biopharma Inc
AMAM
– –
-43,100
ARGX icon
32
argenx
ARGX
$50.2B
– –
-29,500
BMRN icon
33
BioMarin Pharmaceuticals
BMRN
$11.2B
– –
-114,042
EXAS icon
34
Exact Sciences
EXAS
$19.6B
– –
-99,130
1
2